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ABSTRACT: The species 
Harpagophytum procumbens DC. 
is popularly known as devil’s claw 
and is widely used because of its 
anti-inflammatory properties that 
are attributed to an iridoid 
glycoside, the harpagoside. This 
medicinal plant is part of the 
Brazilian List of Essential 
Medicines, that is, it was selected 
and standardized for the resolution 
of diseases in the Brazilian public 
health system (Sistema Único de 
Saúde – SUS) and can be found in 
several brands. Due to the 
importance of quality monitoring, 
the objective of this study was to 
create and validate a method for 
identification and quantification of 
harpagoside in tablets of the 
devil’s claw, as well as to evaluate 
the content of this iridoid glycoside  
in three commercially available brands in Brasília/DF, Brazil. The evaluated parameters in the validation by high performance 
liquid chromatography were linearity, limits of detection and quantification, precision, selectivity, accuracy and robustness, as 
required by the Brazilian regulation. The developed and validated method proved satisfactory for the quality control of 
commercial products that present in this composition the medicinal plant. All the devil’s claw brands presented divergences 
regarding the quality that can interfere with therapeutics and with safety and efficacy. 
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The consumption of herbal medicines grows 
markedly in developed and developing countries1. 
In Brazil, for example, about 85% of the 
population uses some herbal medicine or 
medicinal plant2,3. 
Harpagophytum procumbens DC. belongs to 
the family Pedaliaceae and it is known as devil’s 
claw4. The secondary roots of this medicinal plant 
have been used for centuries for a variety of 
diseases. From ethnological data, this plant is used 
in folk medicine to treat fever, arthritis, skin 
problems, diseases of the digestive tract and as an 
appetite stimulant5. From various studies and 
clinical evidence, devil’s claw is indicated as an 
anti-inflammatory and analgesic in the treatment 
of rheumatic diseases, such as osteoarthritis, in 
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addition to alleviating the symptoms of acute low 
back pain, myalgias and other osteoarticular and 
muscular pathologies5,6. 
The harpagoside is an iridoid glycoside 
considered to be responsible for the 
pharmacological activity of H. procumbens DC. 
This compound is considered the chemical marker 
of this species. Therefore, it is used as a control to 
standardize commercial products7. 
Some factors can compromise the quality of 
herbal products from the cultivation of the raw 
material to the final product, such as 
contamination, the presence of foreign materials, 
botanical identification errors, among others. 
These factors result from the lack of care in the 
collection and identification of the species. Also, 
adulterations are common to increase the yield of 
the product. All these factors affect the quality, 
safety and efficacy of herbal medicines and 
emphasize the importance of quality control from 
the cultivation of the raw material to the finished 
product, as well as phytochemical, 
pharmacological and toxicological studies8,9. 
Chromatographic and analytical techniques are 
used in recognition of the chemical composition, 
including active principle or toxic compound. 
These techniques allow the separation and 
isolation of the substances thus allowing both 
qualitative and quantitative control of the 
compounds considered marker of the species. 
High performance liquid chromatography (HPLC) 
is one of those techniques widely used for the 
complete characterization of plant and herbal 
products, being an important tool in the control of 
the quality of these products9,10. 
Pharmacopoeias and monographs are relevant 
to establish quality standards in addition to 
standardizing and systematizing knowledge of 
medicinal plants. These tools present 
characteristics and properties of plants such as 
macroscopic and microscopic description, general 
aspects of the vegetal drug besides identification, 
purity and assay tests that help in the quality 
control11. 
Pharmacopeial methods (for example, in the 
Brazilian Pharmacopoeia) for the quality control 
of the plant drug Harpagophytum procumbens 
(meaning dried roots of devil’s claw) are 
available. However, there isn’t specific 
monograph for herbal medicines/dosage forms 
containing it12. In the Brazilian Pharmacopeia the 
described method uses flow rate 1.5 mL in an 
isocratic system with water and methanol (50:50). 
In addition, the method refers to the dosage in 
plant drug and not to the finished product12. 
According to the Brazilian regulatory agency 
(Agência Nacional de Vigilância Sanitária – 
Anvisa) when a monograph contemplates only 
analytical method for identification and 
quantification of markers for the vegetal drug, it is 
necessary to make adaptations and validate the 
method for the finished product13. 
In the literature there are other published 
methods for harpagoside determination using 
isocratic or gradient elution with flow rate above 
1 mL min-1 and analysis time around 60 min14,15. 
The proposed method utilizes a flow rate of 
0.6 mL min-1 with gradient mode over 30 min of 
analysis. A quick method with greater solvent 
savings. 
Therefore, this study aimed to develop and 
validate an analytical method using HPLC to 
contribute to the establishment of quality 
parameters for the finished product of this widely 
used medicinal plant, as well as to identify and 
quantify the harpagoside in commercial samples. 
 
2. Materials and methods 
 
2.1 Standard, samples and reagents 
 
Harpagoside, considered chemical marker of 
the species and used for standardization of 
commercial products, was provided by Sigma-
Aldrich. Three different brands of devil’s claw 
tablets were obtained from pharmacies in Brasília, 
Brazil, named as brand A, B and C. About the 
concentration of dry extract of the roots of H. 
procumbens, the brands A, B, and C presented, 
respectively, 200, 400 and 450 mg. Regarding the 
total iridoid equivalents calculated as harpagoside, 
each tablet of the A, B and C brands had declared 
10, 20 and 18 mg, respectively. The solvents 
(HPLC grade) used in the assay were phosphoric 
acid (Sigma), acetonitrile (Tedia) and methanol 
(Tedia). The mobile phase was prepared with 
purified water produced in the Milli-Q system 
(Millipore). 
 
2.2 Sample and standard preparation 
 
Twenty tablets of each brand were macerated 
using mortar and pestle. A portion equivalent to 
40 mg of dry extract of the roots of H. 
procumbens was weighed, solubilized in methanol 
and prepared at the concentration of 4 mg mL-1 
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(this concentration is equivalent to 530 µg mL-1 of 
harpagoside). The resulting solution was filtered 
through a 0.45 µm porosity disposable filter unit 
(Millipore Millex). The harpagoside standard was 
weighed and solubilized in methanol resulting in a 
concentration of 100 µg mL-1. 
 
2.3 Chromatographic conditions 
 
The LaChrom Elite chromatograph (Hitachi, 
Tokyo, Japan) was used for the analysis, contains 
an L2130 pump, L2200 injector, L2455 detector 
and L2300 column oven. The column used was 
the reverse phase C18e Purospher Star (150 × 
4.6 mm, 5 µm, Merck, Germany). The 
temperature conditions, flow, injection volume 
and detection wavelength were 25 °C, 
0.6 mL min-1, 10 µL and 280 nm, respectively. A 
gradient of 1% phosphoric acid and acetonitrile 
(Table 1) was used in the mobile phase. The total 
analysis time was 30 min. 
 
Table 1. Chromatographic conditions of the mobile 
phase gradient. 
 
2.4 Development and validation of the method by 
HPLC-DAD 
 
Leite et al.’s method (2014)16 was used with 
alterations to evaluate the finished product 
referring to devil’s claw. The validation was 
carried out in accordance to the requirements of 
the Brazilian legislation, evaluating the 
parameters of linearity, limits of detection and 
quantification, precision, accuracy, selectivity and 
robustness17 and international guidelines for the 





Linearity was determined from three analytical 
curves with six concentrations of the harpagoside 
standard: 100.0, 200.0, 300.0, 500.0, 700.0 and 
800.0 µg mL-1. From these curves, linearity 
equations were obtained by linear regression. The 
software used to obtain these equations was 
GraphPad Prism Version 6.01 2012. The 
proportional linear relation to the concentration 
and correlation coefficient should be higher than 
0.9900. 
 
2.4.2 Limit of Detection (LOD) and Quantification 
(LOQ) 
 
The slope (s) of the calibration curve and the 
standard deviation (SD) of the three calibration 
curves were considered, taking into account the 
intercept with the Y-axis. These data are used in 
the equations to obtain LOD values and LOQ, that 
is, the smallest amount of marker that can be 
detected and quantified, respectively: 
 




According to the Brazilian legislation, 
precision must be expressed by repeatability, 
intermediate precision or reproducibility17. The 
repeatability determination was performed with 
six replicates with at 100% of the test 
concentration (4 mg mL-1, this concentration is 
equivalent to 530 µg mL-1 of harpagoside) and 
were analyzed on the same day. In the interday 
precision, three replicates with the same 
concentration (4 mg mL-1) were evaluated on 




In this study, the accuracy evaluation was done 
using the standard addition method, using nine 
determinations with three levels of theoretical 
concentration (low, medium and high) in triplicate 
for each level. In the case of finished product, 
according to the Brazilian legislation, if samples 
of all drug components are unavailable, analysis 
by the standard chemical addition method may be 
performed, in which know quantities of reference 
chemical are added to the solution of the finished 
prduct17. The theoretical concentrations used were 
calculated at 80, 100 and 120%; these 
concentrations were achieved using 500 μL of the 
commercial H. procumbens sample with 500 μL 
of the harpagoside standard. The harpagoside 
recovery percentage added to the sample was 
evaluated by the relation between the 
experimentally determined concentration and the 
corresponding theoretical concentration. 
Time / 
min 
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The method ability to identify the harpagoside 
in the presence of impurities, degradation 
compounds or other components in the sample 
was assessed from induction of acidic and basic 
hydrolysis. The assay was done in triplicate, and 
the samples were solubilized using 1 mol L-1 HCl 
for acid hydrolysis and 1 mol L-1 NaOH for basic 
hydrolysis. After solubilization, the samples were 
placed in a water bath for 1 h at 60 °C. After 1 h, 
the samples were taken from the water bath and 
expected to reach room temperature to be 
neutralized with 1 mol L-1 HCl or 1 mol L-1 NaOH 
solution, regarding the sample, and diluted in 
methanol. The final concentration was 4 mg mL-  1. 
The selectivity was evaluated by comparing the 
retention times and peak areas in the samples 
without hydrolysis and the samples submitted to 




The parameters chosen for the variation were 
temperature (23-27 °C), wavelength (270-290 nm) 
and flow of the mobile phase (0.4-0.8 mL min-1). 
From these variations, the effects on the retention 
time and peak area were observed to evaluate if 
the method was robust. 
 
2.5 Identification and quantification of 
harpagoside in commercial samples 
 
The validated method was used to evaluate the 
presence of harpagoside, used to standardize 
commercial products, in the three brands of H. 
procumbens. The harpagoside identification in the 
samples was made comparing the peaks retention 
time and UV spectrum presented by the 
harpagoside standard with the standard peak of 
the samples. The harpagoside quantification was 
made from the linearity curve, in which the 
quantity of this marker could be calculated in the 
samples. 
2.6 Statistical analysis of data 
 
The GraphPad Prism 6.01 software. Data was 
used for the statistical analyzes of the data 
obtained in this study, and the results were 
expressed as the mean ± standard deviation (SD). 
 
3. Results and discussion 
 
3.1 Method validation 
 
The method was optimized for a 30 min 
analysis time (while the original method was 55 
min) using a C18e Purospher Star reverse phase 
column (150 × 4.6 mm, 5 µm). The mobile phase 
used was a gradient of 1% phosphoric acid and 
acetonitrile using a flow rate of 0.6 mL min-1, 
injection volume of 10 µL and the chromatograms 
extracted at 280 nm wavelength. 
Some parameters were evaluated for system 
suitability such as resolution (3.90 ± 0.03), 
retention time (15.85 ± 0.01), repeatability 
(14,600,558 ± 629,334), plate number (13713 ± 
379) and tailing factor (1.2 ± 0.1). 
 
3.1.1 Linearity, limit of detection (LOD) and limit 
of quantification (LOQ) 
 
The method presented a linear response in the 
range of 100 to 800 μg mL-1 of concentrations. 
This correlation was made between the area of the 
peaks and their respective concentrations in 
triplicate. According to the Brazilian legislation, 
the correlation coefficient should be higher than 
0.9900, and the method under study had a 
correlation coefficient of 0.9992, according to the 
requirements, demonstrating the linearity of the 
method15. From the linearity curve, LOD and 
LOQ were obtained: 1.12 μg mL-1 and 
3.39 μg mL-1, respectively. The linearity and 
dispersion of residues graph are shown in Fig. 1. 
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Regarding the precision of the results, the 
method demonstrated repeatability when 
presenting a standard deviation between the 
replicates of 4.31% for the intraday precision and 
4.06% for the interday precision, not higher than 




The accuracy of the method was evaluated by 
the standard addition method to the samples of 
known concentration. The objective of this 
method is to identify and quantify the harpagoside 
in commercial samples for that reason, the 
percentage of recovery the closer to 100%, more 
accurate the method will be for this quantification. 
The obtained results showed this proximity, 
confirming that the method is accurate for the 
proposed objective, presenting a relative standard 
error of less than 5% (Table 2). 
















100.869 (80%) 97.2 ± 0.1 96.33 3.67 
126.087 (100%) 120.0 ± 0.3 95.20 4.80 
151.304 (120%) 150 ± 1 99.02 0.98 




The purity of the peak of interest in the sample 
without acid or basic hydrolysis was pure = 1.00 ± 
0.00. The method was selective to demonstrate 
that after induction of acidic and basic hydrolysis 
there was a complete degradation of the 
harpagoside peak and formation of degradation 
compounds (a degradation product peak formed 
with a purity of 0.995 ± 0.005 with retention time 
19.870 ± 0.007 min in basic hydrolysis and 0.94 ± 
0.04 with retention time 19.890 ± 0.003 min in 
acid hydrolysis), and there was no co-elution of 
these with the peak of the marker. In this way, the 
method can identify and quantify the harpagoside 




After the variations in wavelength and 
temperature parameters, no significant changes in 
the retention time and area of the harpagoside 
peak was observed. These results demonstrate that 
the proposed method is robust. However, 
regarding the flow variation, considerable changes 
in the retention time and area of the peak were 
observed, as can be seen in Table 3. From these 
results, the flow is a parameter that must be very 
well accompanied because the notorious influence 
on the separation of substances and especially on 









Table 3. Parameters for analysis for robustness of the HPLC analytical method. 
Wavelength / nm Peak area / mAU Retention time / min 
270  12,578,713 ± 512,794 15.82 ± 0.01 
280  14,070,719 ± 585,792 15.82 ± 0.01 
290  12,045,012 ± 494,637 15.82 ± 0.01 
Temperature / °C Peak area / mAU Retention time / min 
23 14,795,700 ± 87,333 15.802 ± 0.01 
25 14,853,562 ± 133,593 15.811 ± 0.01 
27 15,183,982 ± 120,467 15.804 ± 0.01 
Flow / mL min-1 Peak area (mAU) Retention time (min.) 
0.4  20,944,078 ± 211,746 20.19 ± 0.01 
0.6  14,122,976 ± 174,969 15.807 ± 0.01 
0.8  10,859,776 ± 27,804 13.445 ± 0.01 
 
3.2 Identification and quantification of 
harpagoside in commercial samples 
 
The method developed and duly validated 
according to the legislation was used to identify 
and quantify harpagoside in the three commercial 
brands of H. procumbens available in Brasília/DF, 
Brazil. The chromatographic profiles were 
obtained using the proposed analytical method, 
and harpagoside was identified in the samples 
from the retention time and UV spectrum (Fig. 2). 
All brands presented the harpagoside in its 
composition. The harpagoside was possible to 
quantify from the peak area of the marker, and all 
the brands had concentrations in inadequate 
amounts compared to the concentration declared 
in the package inserts (Table 4). The declared 
values compared to the amount found 
experimentally presented a variation in 













Figure 2. Chromatographic profiles of the brands A, B and C of the herbal medicine Harpagophytum procumbens 
obtained using HPLC-DAD with detection at 280 nm. 1: Harpagoside. 
 
Table 4. Harpagoside concentration in Harpagophytum procumbens DC tablets and experimentally 
determined daily dose compared to the concentration stated in the package inserts. 
Brand 
Concentration of harpagoside / mg mL
-1
 *Variation of 
harpagoside 
concentration / % 
**Daily dose of 
harpagoside / mg Declarated Determinated 
A 0.05 0.0290 ± 0.0009 - 42.00 17.40 
B 0.05 0.064 ± 0.001 + 28.00 76.80 
C 0.04 0.0510 ± 0.0002 + 27.50 68.70 
* Variation allowed by the Brazilian legislation is ± 15%13 
** Daily dose recommended by the Brazilian legislation is 30 to 100 mg17 
 
For all brands, the suggested posology was one 
tablet three times a day. To find the daily doses, a 
relation between the declared value and the 
experimentally determined harpagoside content 
was done. The results showed that, regarding the 
daily posology, all brands were out the 
specifications determined by the Brazilian 
legislation (30 to 100 mg)13 (Table 4). This fact 
can imply in possible toxic effects due to an 
overdosage, considering the active principle of 
herbal medicines presents pharmacological 
action19. Therefore, these results suggest a serious 
health risk due to therapeutic failure or toxicity. 
One study demonstrated that the majority of 
patients responded more to treatment using the 
highest daily dose of harpagoside (100 mg), as 
well as the adverse events are predictable and 
dose-dependent. The active principle is bitter and 
stimulates the production of gastrointestinal juice. 











The proposed method in this study for the 
identification and quantification of harpagoside in 
the herbal medicine devil’s claw was efficient and 
quick to evaluate the quality of these products to 
ensure authenticity, credibility, safety and 
therapeutic efficacy. The obtained results 
emphasize the importance of quality control since 
we observed, in all three medicinal products, 
significant variations in the quantity of 
harpagoside in comparison to the value declared 
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